Deauville Criteria

The Deauville 5-point scoring system is an internationally accepted and utilized five-point scoring system for the fluorodeoxyglucose (FDG) avidity of a Hodgkin lymphoma or Non-Hodgkin lymphoma tumor mass as seen on FDG positron emission tomography:^[1]

Score 1: No uptake above the background
Score 2: Uptake ≤ mediastinum
Score 3: Uptake > mediastinum but ≤ liver
Score 4: Uptake moderately increased compared to the liver at any site
Score 5: Uptake markedly increased compared to the liver at any site
Score X: New areas of uptake unlikely to be related to lymphoma

Scores of 1 and 2 are considered to be negative and 4 and 5 are considered to be positive. "Score 3 should be interpreted according to the clinical context but in many Hodgkin Lymphoma patients indicates a good prognosis with standard treatment." ^[2]

History edit

Deauville score was developed at Guy's and Saint Thomas Hospital in London after an international meeting at Deauville, France in 2009.

References edit

^ Barrington et al., Eur J Nucl Med Mol Imaging (2010) 37:1824–1833
^ Follows et al, British Journal of Haematology, 2014, 166, 34–49.

This article related to medical imaging is a stub. You can help Wikipedia by expanding it.

[1] Barrington et al., Eur J Nucl Med Mol Imaging (2010) 37:1824–1833

[2] Follows et al, British Journal of Haematology, 2014, 166, 34–49.

[1]

[2]